Tauriga Sciences, Inc. Completes Initial Tauri-Gummies Production Run; CBD Isolate Concentration Increased to 25mg per Each Vegan Gum Drop

NEW YORK, NY - (NewMediaWire) - December 6, 2019 - Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating Company that operates through the development, distribution, and licensing of proprietary products as well as the evaluation of potential acquisition opportunities and equity investments, today announced that it has completed its initial Tauri-Gummies™ production run.  The Company increased the concentration of CBD Isolate from 15mg to 25mg per each Vegan Gum Drop and from 360mg to 600mg per each Tauri-Gummies™Jar (“Jar”).  Each Jar will be comprised of 24 Vegan Gum Drops; 6 Cherry Flavor (Colored Red), 6 Lemon Flavor (Colored Yellow), 6 Orange Flavor (Colored Orange), and 6 Lime Flavor (Colored Green).  This initial Tauri-Gummies™production run yielded an inventory of 1,000 Jars (24,000 Gum Drops).  The Company expects that its Tauri-Gummies™ product will be available to the retail marketplace, within the next few weeks. The anticipated Manufacturer’s Suggested Retail Price (“MSRP”) has been set at $24.99 per Jar.      

The Company is currently completing its graphic design and artwork for the final Tauri-Gummies™ label as well as the logo.  The Company is pleased to report that it has secured a Certificate of Analysis (“C of A”) for its Tauri-Gummies™ product, from San Diego, California based Infinite Chemical Analysis Labs. In addition, there is $3,000,000 in product liability insurance coverage – in place – for the Tauri-Gummies™ product.  The Company is in the process of obtaining a Kosher Certification for Tauri-Gummies™, and has contacted Star-K to complete this task (Star-K is the Kosher Authority that certified Tauri-Gum™ on January 29, 2019).

Tauriga Sciences Inc. formulated and developed its Tauri-Gummies™ product to be Vegan.  This was accomplished by substituting plant based gelling and thickening agent(s) (i.e. Pectin) as a replacement for Gelatin. There is NO Gelatin in the Tauri-Gummies™ product!

ABOUT TAURIGA SCIENCES INC.

Tauriga Sciences, Inc. (TAUG) is a revenue generating Company that operates through the development, distribution, and licensing of proprietary products as well as the evaluation of potential acquisition opportunities. One such opportunity on which the Company has acted, involves the Company having entered into the cannabidiol (or “CBD”) infused chewing gum product business, as more fully described above and in prior press releases.  This CBD infused chewing gum product has been branded under the following name: Tauri-Gum™.  The Company is currently in production of three distinct flavors of Tauri-Gum™: MINT, BLOOD ORANGE, and POMEGRANATE.  On December 6, 2019 the Company announced that it completed the initial production run (thereby expanding its existing product lines) with the introduction of a 25mg Vegan CBD Isolate Infused vegan gummy (“gum drop”), branded under the name: Tauri-Gummies™.  Further, the Company continues to identify and evaluate additional potential opportunities to generate revenue, as well as shareholder value, and leverage its resources and expertise to build a diversified and sustainable business model. Please visit our corporate website at www.tauriga.com.

In addition, on March 11, 2019, the Company announced the official launch of its E-Commerce site - as part of its Tauri-Gum™ commercialization strategy.  This site can be accessed by visiting the following URL address:  www.taurigum.com

The Company has established corporate offices in both New York City (USA) and Barcelona (Spain).  

DISCLAIMER -- Forward-Looking Statements

This press release contains certain “forward-looking statements” as defined by the Private Securities Litigation Reform Act of 1995 which represent management’s beliefs and assumptions concerning future events. These forward-looking statements are often indicated by using words such as “may,” “will,” “expects,” “anticipates,” believes, “hopes,” “believes,” or plans, and may include statements regarding corporate objectives as well as the attainment of certain corporate goals and milestones. Forward-looking statements are based on present circumstances and on management’s present beliefs with respect to events that have not occurred, that may not occur, or that may occur with different consequences or timing than those now assumed or anticipated. Actual results may differ materially from those expressed in  forward looking statements due to known and unknown risks and uncertainties, such as are not guarantees of general economic and business conditions, the ability to successfully develop and market products, consumer and business consumption habits, the ability to consummate successful acquisition and licensing transactions, fluctuations in exchange rates, and other factors over which Tauriga has little or no control. Many of these risks and uncertainties are discussed in greater detail in the “Risk Factors” section of Tauriga’s Form 10-K and other filings made from time to time with the Securities and Exchange Commission. Such forward-looking statements are made only as of the date of this release, and Tauriga assumes no obligation to update forward-looking statements to reflect subsequent events or circumstances. You should not place undue reliance on these forward-looking statements.

Contact:

CONTACT INFORMATION

Tauriga Sciences, Inc.
555 Madison Avenue, 5th Floor
New York, NY  10022
Chief Executive Officer
Mr. Seth M. Shaw
Email:  sshaw@tauriga.com
cell # (917) 796 9926
Corp. Website:   www.tauriga.com

E-Commerce Website:  www.taurigum.com